152 related articles for article (PubMed ID: 6332858)
1. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype.
Stevens RL; Bloes WF; Seldin DC; Razin E; Katz HR; Austen KF
J Immunol; 1984 Nov; 133(5):2674-80. PubMed ID: 6332858
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.
Razin E; Ihle JN; Seldin D; Mencia-Huerta JM; Katz HR; LeBlanc PA; Hein A; Caulfield JP; Austen KF; Stevens RL
J Immunol; 1984 Mar; 132(3):1479-86. PubMed ID: 6198393
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
Robin JL; Seldin DC; Austen KF; Lewis RA
J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947
[TBL] [Abstract][Full Text] [Related]
4. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
5. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
[TBL] [Abstract][Full Text] [Related]
6. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells.
Katz HR; Raizman MB; Gartner CS; Scott HC; Benson AC; Austen KF
J Immunol; 1992 Feb; 148(3):868-71. PubMed ID: 1309842
[TBL] [Abstract][Full Text] [Related]
7. Ontogeny of in vitro-differentiated mouse mast cells.
Stevens RL; Rothenberg ME; Levi-Schaffer F; Austen KF
Fed Proc; 1987 Apr; 46(5):1915-9. PubMed ID: 3549363
[TBL] [Abstract][Full Text] [Related]
8. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
9. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM
J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578
[TBL] [Abstract][Full Text] [Related]
10. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA
J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233
[TBL] [Abstract][Full Text] [Related]
11. Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin: their increase after sodium butyrate treatment of the cells.
DuBuske L; Austen KF; Czop J; Stevens RL
J Immunol; 1984 Sep; 133(3):1535-41. PubMed ID: 6205085
[TBL] [Abstract][Full Text] [Related]
12. Proliferation and functional responses of bone marrow-derived mast cells after activation.
Levi-Schaffer F; Shalit M
Cell Immunol; 1993 May; 148(2):435-43. PubMed ID: 8495499
[TBL] [Abstract][Full Text] [Related]
13. [The culture of mouse bone marrow-derived mast cells (BMMC) and the anaphylactic release of chemical mediators].
Yamamura H; Ohkawa E; Kohno S; Ohata K
Arerugi; 1992 Sep; 41(9):1367-79. PubMed ID: 1280088
[TBL] [Abstract][Full Text] [Related]
14. IL-4 renders mast cells functionally responsive to endothelin-1.
Egger D; Geuenich S; Denzlinger C; Schmitt E; Mailhammer R; Ehrenreich H; Dörmer P; Hültner L
J Immunol; 1995 Feb; 154(4):1830-7. PubMed ID: 7530742
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 3-dependent mouse mast cells express the cholera toxin-binding acidic glycosphingolipid, ganglioside GM1, and increase their histamine content in response to toxin.
Katz HR; Levine JS; Austen KF
J Immunol; 1987 Sep; 139(5):1640-6. PubMed ID: 2957431
[TBL] [Abstract][Full Text] [Related]
16. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
[TBL] [Abstract][Full Text] [Related]
17. Identification of the neutral glycosphingolipids of murine mast cells: expression of Forssman glycolipid by the serosal but not the bone marrow-derived subclass.
Katz HR; Schwarting GA; LeBlanc PA; Austen KF; Stevens RL
J Immunol; 1985 Apr; 134(4):2617-23. PubMed ID: 3871816
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the growth rate of mouse fibroblasts by IL-3-activated mouse bone marrow-derived mast cells.
Dayton ET; Caulfield JP; Hein A; Austen KF; Stevens RL
J Immunol; 1989 Jun; 142(12):4307-13. PubMed ID: 2786027
[TBL] [Abstract][Full Text] [Related]
19. Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker.
Serafin WE; Dayton ET; Gravallese PM; Austen KF; Stevens RL
J Immunol; 1987 Dec; 139(11):3771-6. PubMed ID: 3680950
[TBL] [Abstract][Full Text] [Related]
20. Activation- and phorbol ester-stimulated phosphorylation of a plasma membrane glycoprotein antigen expressed on mouse IL-3-dependent mast cells and serosal mast cells.
Katz HR; Benson AC; Austen KF
J Immunol; 1989 Feb; 142(3):919-26. PubMed ID: 2464032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
